Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 976 AL 990

Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging

Cho ZH, Min HK, Oh SH, Han JY, Park CW, Chi JG, Kim YB, Paek SH, Lozano AM, Lee KH.

J Neurosurg. 2010 Sep;113(3):639-47. doi: 10.3171/2010.3.JNS091385.

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies

Lopes FM, Schröder R, da Frota ML Jr, Zanotto-Filho A, Müller CB, Pires AS, Meurer RT, Colpo GD, Gelain DP, Kapczinski F, Moreira JC, Fernandes Mda C, Klamt F.

Brain Res. 2010 Jun 14;1337:85-94. doi: 10.1016/j.brainres.2010.03.102. Epub 2010 Apr 7.

MicroRNAs as biomarkers for CNS cancer and other disorders

De Smaele E, Ferretti E, Gulino A.

Brain Res. 2010 Jun 18;1338:100-11. doi: 10.1016/j.brainres.2010.03.103. Epub 2010 Apr 7.

Detection of imminent collisions by drivers with Alzheimer's disease and Parkinson's disease: a preliminary study

Vaux LM, Ni R, Rizzo M, Uc EY, Andersen GJ.

Accid Anal Prev. 2010 May;42(3):852-8. doi: 10.1016/j.aap.2009.07.009.

Tolcapone improves sleep in patients with advanced Parkinson's disease (PD)

Ebersbach G, Hahn K, Lorrain M, Storch A.

Arch Gerontol Geriatr. 2010 Nov-Dec;51(3):e125-8. doi: 10.1016/j.archger.2010.03.008. Epub 2010 Apr 8.

Parkinson's disease as a disconnection syndrome

Cronin-Golomb A.

Neuropsychol Rev. 2010 Jun;20(2):191-208. doi: 10.1007/s11065-010-9128-8. Epub 2010 Apr 10.

Effects of dietary factors on levodopa pharmacokinetics

Fernandez N, Garcia JJ, Diez MJ, Sahagun AM, Díez R, Sierra M.

Expert Opin Drug Metab Toxicol. 2010 May;6(5):633-42. doi: 10.1517/17425251003674364.

A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease

Chu CT.

Hum Mol Genet. 2010 Apr 15;19(R1):R28-37. doi: 10.1093/hmg/ddq143. Epub 2010 Apr 12.

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial

Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP.

Neurology. 2010 Apr 13;74(15):1203-7. doi: 10.1212/WNL.0b013e3181d8c1b7.

Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases

Krainc D.

Arch Neurol. 2010 Apr;67(4):388-92. doi: 10.1001/archneurol.2010.40.

Noncompacted ventricular myocardium: is syncope the only warning sign?

Ho TQ, Lenihan DJ, Kantharia BK, Dougherty AH.

Am J Med Sci. 2010 May;339(5):497-500. doi: 10.1097/MAJ.0b013e3181d96ea8.

Treatment of benign essential blepharospasm with finasteride: a case report

Bortolato M, Cannas A, Solla P, Puligheddu M, Muroni A, Marrosu F.

Clin Neuropharmacol. 2010 Jul;33(4):207-8. doi: 10.1097/WNF.0b013e3181dca96f.

Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor

Cui WY, Li MD.

J Neuroimmune Pharmacol. 2010 Dec;5(4):479-88. doi: 10.1007/s11481-010-9210-2. Epub 2010 Apr 13.

The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders

Lanni C, Stanga S, Racchi M, Govoni S.

Curr Pharm Des. 2010;16(6):698-717. doi: 10.2174/138161210790883741.

[Apathy in Parkinson's disease]

García-Ramos R, Villanueva C, del Val J, Matías-Guíu J.

Neurologia. 2010 Jan-Feb;25(1):40-50.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias